Medicines and Healthcare products Regulatory Agency

(asked on 20th June 2016) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what plans he has for the Medicines and Healthcare Products Regulatory Agency to contribute to the Government's aim of reducing the regulatory burden on business by £10 billion in 2016-17; and if he will make a statement.


Answered by
George Freeman Portrait
George Freeman
This question was answered on 30th June 2016

The Medicines and Healthcare products Regulatory Agency (MHRA), with the Department’s other arm’s length bodies, is expected to contribute to the Department’s contribution to the Business Impact Target and the continued drive to reduce the burden of regulations. The MHRA has developed, in partnership with industry, a burden reduction plan to deliver proportionate regulation and minimise the regulatory burden on industry, while safeguarding public health. Industry partners have been asked to identify potential monetary savings from these actions. The Department will hold the MHRA to account for delivery against this plan.

Reticulating Splines